Search
for
Sort by
Research 31–60 of 869
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- SUMMARIES OF PAPERS
- Reexamining the Role of Diet in Dermatology
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- The use of cyclosporine in dermatology: Part I
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review
- JAK inhibition decreases the autoimmune burden in Down syndrome
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Seasonal Patterns and Trends in Dermatoses in Poland
- The brain–gut–skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier
- Skin manifestations associated with systemic diseases – Part I
- Role of DNA Methylation in the Pathogenesis of Skin Disorders: Mechanisms, Inhibitors of Methylation‐Related Enzyme, and Molecular Docking Studies
- Westwood Carolina Conference on Clinical Dermatology
- AN SYNOPTIC OVERVIEW ON AUTOIMMUNE DISORDERS AND ITS MANAGEMENT
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Immunosuppressive therapy in autoimmune disease — A review
- JAK inhibitors in dermatology: The promise of a new drug class
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Stem Cell Use to Treat Dermatological Disorders
- Stem-cell therapy in dermatology – Challenges and opportunities
- The JAK/STAT signaling pathway: from bench to clinic
- Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery
- Stem Cell Secretome for Skincare: Of Cell Types, Exosomes, Extracellular Vesicles, and Soluble Fractions
- Swellable Microneedles in Drug Delivery and Diagnostics
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus